Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States. (8th February 2015) - Arellano, Jorge
Abstract In patients with bone metastases secondary to solid tumors, the 5‐year prevalence was 43% for renal impairment (RI) and 71% for chronic kidney disease among evaluable RI patients. Whenever possible, treatments that are potentially less damaging for the kidney should be considered for patients with or predisposed to RI.